-
21
Impact of the crosstalk between the PTEN and PAFR as well as PAFR and EGFR pathways in cancer
Published 2025-01-01Subjects: Get full text
Article -
22
-
23
Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Adv...
Published 2023-07-01Subjects: “…hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer…”
Get full text
Article -
24
-
25
Predictive and Prognostic Molecular Markers of Oral Cancers and Potential Therapeutic Agents Targeting These Markers
Published 2024-08-01Subjects: “…epidermal growth factor receptor…”
Get full text
Article -
26
-
27
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
Published 2025-01-01Subjects: Get full text
Article -
28
EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells
Published 2025-01-01Subjects: Get full text
Article -
29
Emerging targeted therapies in oral oncology: Focus on EGFR inhibition
Published 2024-09-01Subjects: “…Epidermal growth factor receptor (EGFR)…”
Get full text
Article -
30
Analysis of risk factors for radiation-induced oral mucositis for nasopharyngeal carcinoma and prognostic value of EGF and STREM-1
Published 2025-01-01Subjects: Get full text
Article -
31
The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways
Published 2024-11-01Subjects: Get full text
Article -
32
Mogroside ⅡE, an in vivo metabolite of sweet agent, alleviates acute lung injury via Pla2g2a-EGFR inhibition
Published 2024-01-01Subjects: Get full text
Article -
33
Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Published 2025-02-01Subjects: Get full text
Article -
34
Quercetin inhibits truncated isoform of dopamine- and cAMP-regulated phosphoprotein as adjuvant treatment for trastuzumab therapy resistance in HER2-positive breast cancer
Published 2024-09-01Subjects: “…p95-human epidermal growth factor receptor 2 (her2)…”
Get full text
Article -
35
Characterisation of IGF-1 (rs7136446) and IL-6 (rs1800795) polymorphisms among breast cancer patients in western Algeria
Published 2024-10-01Subjects: Get full text
Article -
36
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Published 2025-01-01Subjects: “…hormone receptors human epidermal growth factor receptor 2 (HER2)…”
Get full text
Article